Everything tagged "margins" across research, earnings, and macro.
6 articles
Rivian’s R2 launch is finally moving from story stock fuel to an execution exam, and the market is reacting accordingly. A company with a negative 1.7% gross margin and fresh workforce cuts tied to profitability does not get the benefit of the doubt on a major volume ramp.
TSMC is not just riding the AI boom; it is one of the bottlenecks making that boom possible. When management says it will take a "very long time" to meet demand, that reads like scarcity power, and the numbers still back it up.
Graham has moved into a more durable growth phase, powered by record backlog, defense-heavy demand, and improving margins. But the stock already prices in much of that progress, leaving a Hold case despite strong operating momentum.
Workday's latest quarter gave software bulls exactly what they needed: proof that AI is showing up in product usage and margin expansion at the same time. The stock still has work to do after a brutal YTD drawdown, but this report made the disruption narrative a lot harder to sell.
Medline is growing at scale with strong customer retention and a deep med-surg distribution network, but margin pressure and a rich valuation keep the stock from looking cheap.
Fair Isaac is a high-margin compounder with dominant credit-scoring economics and growing software momentum. The stock looks constructive, but its premium valuation leaves little room for execution misses.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator